Yoon Duk Hong

Also affiliated with National Cancer Institute, Kelly Services (United States)

Economics, Econometrics and FinanceMedicineMathematics

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Use of pembrolizumab among older adults with cancer in the United States, before and after FDA approval of its tumor‐agnostic indication”.

Use of pembrolizumab among older adults with cancer in the United States, before and after FDA approval of its tumor‐agnostic indication

Pharmacoepidemiology and Drug Safety(2023)10.1002/pds.5745

N/A

0DataRank · unranked

1 citations

Lindsey Enewold, Michael T. Halpern, Chris Zeruto, Angela B. Mariotto, Yoon Duk Hong

Assessing 1-Year Comorbidity Prevalence and Its Survival Implications in Medicare Beneficiaries Diagnosed with Cancer: Insights from a New SEER–Medicare Resource

Cancer Epidemiology Biomarkers & Prevention(2024)10.1158/1055-9965.epi-24-0833

N/A

0DataRank · unranked

4 citations

Angela B. Mariotto, Yoon Duk Hong, Lindsey Enewold, Anne‐Michelle Noone

Evolving patterns in systemic treatment utilization and survival among older patients with advanced cutaneous melanoma

Cancer Medicine(2024)10.1002/cam4.70131

N/A

0DataRank · unranked

4 citations

Lindsey Enewold, Elad Sharon, Jeremy L. Warner, Amy J. Davidoff, Chris Zeruto +2 more